Abstract
The number of clinically-recognized, genetically-defined inborn errors of immunity (IEI) is rapidly growing due to expanded testing options. In particular, next generation sequencing (NGS) panels are an affordable and rapid method for identifying IEIs. This study evaluated the diagnostic yield of clinically available NGS panels, and documented key clinical features and laboratory findings associated with diagnosis of IEI.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
